Latest Medicamen Biotech stock price

Medicamen Biotech P/E Ratio

MEDICAMEQ • P/E ratio trend, valuation band, and sector comparison — all formatted to support journal-based trading review.
Current P/E Ratio
57.88
High Valuation
Very High - High growth expectations or significantly overvalued

Current Valuation Metrics

P/E Ratio 57.88
Current Price ₹400.20
EPS (TTM) ₹5.60
Exchange NSE

Valuation Signal

Signal Overvalued
Historical Avg 70.86
Historical Range 30.93 - 112.62
Percentile 50.0%

Sector Context

Sector Average 57.32
Sector Median 35.38
Sector Rank #11 of 88
Sector Percentile 12.5%

Earnings Breakdown (TTM)

TTM EPS ₹4.92
Sept 2025 ₹1.56
Mar 2025 ₹1.47

Key P/E Ratio Insights for Medicamen Biotech

  • Stock appears overvalued with PE of 57.88, suggesting caution for new investments

View the MEDICAMEQ equity price for detailed stock performance.

P/E Ratio Historical Trend for Medicamen Biotech

Historical P/E ratio trend based on annual earnings data. Lower P/E ratios may indicate undervaluation, while higher ratios suggest growth expectations.

Historical P/E Ratio Data

Year P/E Ratio EPS (₹) Year-end Price (₹) Exchange Valuation
2024 112.62 5.25 ₹591.25 NSE High
2023 97.16 8.92 ₹866.70 NSE High
2022 88.94 11.02 ₹980.10 NSE High
2021 42.66 12.94 ₹552.00 NSE High
2020 52.86 9.0 ₹475.75 BSE High
2019 30.93 11.04 ₹341.50 BSE High

Sector P/E Ratio Comparison

Comparing Medicamen Biotech with other companies in Healthcare sector
Sector Average
57.32
Sector Median
35.38
Lowest P/E
9.01
Highest P/E
515.32
Companies
88
Company Symbol P/E Ratio Market Cap (₹ Cr) Valuation
Fermenta Biotech FERMENTA 9.01 ₹1,010 Low
Natco Pharma NATCOPHARM 10.8 ₹17,006 Low
Mohini Health & Hygiene MHHL 11.84 ₹69 Low
Lincoln Pharmaceuticals LINCOLN 12.02 ₹974 Low
QMS Medical Allied Servi… QMSMEDI 12.82 ₹177 Low
Take Solutions TAKE 13.15 ₹638 Low
Venus Remedies VENUSREM 14.27 ₹995 Low
Royal Sense ROYAL 14.5 ₹96 Low
Bliss GVS Pharma BLISSGVS 16.62 ₹1,973 Moderate
RPG Life Sciences RPGLIFE 17.94 ₹3,861 Moderate